Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase EARLY_PHASE1 1

Status

Completed 4Unknown 2Terminated 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Pain 2Neoplasms 1Emergencies 1

Interventions

Saline Solution 6Letrozole 6Fentanyl 6Sodium Chloride 5Dexamethasone 5Pregabalin 4Ketamine 4Goserelin 4Gemcitabine 4Bevacizumab 4Tranexamic Acid 3Photochemotherapy 3Pemetrexed 3Paclitaxel 3Metformin 3Leuprolide 3Docetaxel 3Cyclophosphamide 3Carboplatin 3Capecitabine 3Acetaminophen 3ulipristal acetate 2sodium glycididazole 2nilotinib 2liposomal doxorubicin 2human papillomavirus vaccine, L1 type 16, 18 2flurbiprofen axetil 2fludarabine 2fluciclovine F-18 2epoetin beta 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Hydromorphone × Clear all
NCT01812759 2021-06-29

Fentanyl for Breakthrough Pain in the Emergency Department

M.D. Anderson Cancer Center

Phase 4 Terminated
3 enrolled 8 charts

Emergencies, Pain

NCT01648699 2013-10-11

Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain

Janssen Pharmaceutica

Phase 4 Terminated
20 enrolled 9 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡